File Analysis of Falling Patients: Are Drugs Frequently Involved

NCT04787146 | Completed

• 1 other identifier: ADOPAC
• Study Type: observational
• Target: 52
• Locations: 1 country
• Sites: 1

Brief Summary

The damage caused by patient falls is a major public health problem, due to the large and growing number of people concerned, the potentially serious consequences but also the financial cost generated by their care. These consequences can be physical as well as psychological. Fractures and pain are the first consequences that come to mind, but many others should be mentioned: post-fall syndrome, loss of autonomy or even entering an institution, fear of falling, loss of confidence in itself.

Conditions

Fall Patients

Keywords

Drugs

Outcome Measures

Primary Outcomes (1)

• To assess the prevalence of falls associated with one or more risk factors for drug iatrogenism within the Paris Saint-Joseph Hospital Group.

  Percentage of falls involving one or more drugs at risk of falling

  1 week

Secondary Outcomes (3)

• List the drug treatments at risk taken by patients who fall

  1 week

• Evaluate the relevance of drug prescriptions in patients who fall

  1 week

• Evaluate the overall compliance of falling patients

  1 week

Study Arms (1)

Patients

From Monday to Friday, the study will be offered to patients selected consecutively and who have fallen within the previous 24 hours (between 7.55 a.m. the day before and 7.55 a.m. the next day). After delivery of the written information note to the patient, the investigating physician answers the patient's questions and accepts his non-objection. The patient should be given sufficient time to think things through to make the decision to participate in the study. Its non-opposition will be traced in the computerized medical file created on the day of its inclusion in the protocol. Each patient participating in the study retains the possibility of participating simultaneously in another research. No exclusion period is provided for in the protocol.

Other: No intervention

Interventions

No intervention OTHER

Once the patient is included, a drug assessment is carried out as part of the treatment and then an compliance questionnaire is submitted to him.

Patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

From Monday to Friday, the study will be offered to patients selected consecutively and who have fallen within the previous 24 hours (between 7.55 a.m. the day before and 7.55 a.m. the next day).

You may qualify if:

• Major patient
• French-speaking patient
• Patient hospitalized within the Paris Saint-Joseph Hospital Group
• Patient who fell during hospitalization and for whom a fall report has been completed

You may not qualify if:

• Patients in the process of therapeutic limitation
• Patient under guardianship or curatorship
• Patient deprived of liberty
• Patient objecting to participation in the study
• Patient under legal protection

Sponsors & Collaborators

• Fondation Hôpital Saint-Joseph: lead

Study Sites (1)

Groupe Hospitalier Paris Saint-Joseph

Paris, Île-de-France Region, 75014, France

Location

Study Officials

• Elodie MENAGE

  Fondation Hôpital Saint-Joseph

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 1, 2021
• First Posted: March 8, 2021
• Study Start: April 18, 2019
• Primary Completion: October 15, 2019
• Study Completion: February 28, 2021
• Last Updated: March 8, 2021

Record last verified: 2021-03

Locations

FR (1)